abstract |
The present invention relates to genetically modified eukaryotic cells comprising one or more heterologous genes encoding: a) d-glucose-6-phosphate dehydrogenase and/or b) 6-phosphogluconate dehydrogenase; and/or c) glucose dehydrogenase, gluconolactonase and gluconokinase, wherein the glucose dehydrogenase in a), b) and c) is NAD + Is dependent. |